BioScience Health Innovations, Inc.
BHIC
$4.00
-$32.04-88.90%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 207.22% | 260.04% | 231.53% | 208.73% | 358.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 207.22% | 260.04% | 231.53% | 208.73% | 358.81% |
| Cost of Revenue | 417.72% | 565.10% | 445.04% | 373.92% | 546.98% |
| Gross Profit | 149.32% | 190.27% | 184.88% | 170.21% | 324.94% |
| SG&A Expenses | 81.74% | 75.44% | 51.57% | 66.04% | 125.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 156.09% | 161.09% | 106.81% | 107.04% | 163.15% |
| Operating Income | 2,194.56% | 1,372.69% | 342.19% | 134.59% | 116.45% |
| Income Before Tax | 2,194.56% | 1,372.69% | 342.19% | 134.59% | 113.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2,194.56% | 1,372.69% | 342.19% | 134.59% | 113.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2,194.56% | 1,372.69% | 342.19% | 134.59% | 113.18% |
| EBIT | 2,194.56% | 1,372.69% | 342.19% | 134.59% | 116.45% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 2,205.71% | 1,243.42% | 324.46% | 121.30% | 105.15% |
| Normalized Basic EPS | 2,095.65% | 1,282.61% | 326.21% | 121.99% | 105.41% |
| EPS Diluted | 1,712.24% | 632.50% | 264.98% | 117.48% | 92.78% |
| Normalized Diluted EPS | 2,400.00% | 1,242.55% | 322.76% | 120.75% | 104.71% |
| Average Basic Shares Outstanding | 5.27% | 5.03% | 4.73% | 24.24% | 59.82% |
| Average Diluted Shares Outstanding | 5.46% | 7.31% | 7.32% | 27.04% | 61.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |